Centessa Pharmaceuticals PLC ADR
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $15,000 | $952 |
Gross Profit | -228 | 15,000 | 476 | |
EBITDA | -51,598 | -46,455 | -21,644 | -107,570 |
EBIT | -51,835 | -46,681 | -21,861 | -107,800 |
Net Income | -54,891 | -50,343 | -26,135 | -111,329 |
Net Change In Cash | 0 | 0 | 15,000 | 952 |
Free Cash Flow | -58,546 | -22,578 | -57,246 | -42,800 |
Cash | 50,811 | 44,242 | 105,156 | 383,221 |
Basic Shares | 134,163 | 133,677 | 133,034 | 132,050 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $6,853 | $0 |
Gross Profit | -942 | 6,853 | -131 |
EBITDA | -221,881 | -165,425 | -209,546 |
EBIT | -222,823 | -166,235 | -209,677 |
Net Income | -235,757 | -151,085 | -216,207 |
Net Change In Cash | 0 | 6,853 | 0 |
Free Cash Flow | -142,089 | -160,511 | -201,683 |
Cash | 383,221 | 128,030 | 393,644 |
Basic Shares | 114,473 | 96,178 | 93,400 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0 |
2025-09-30 | -$0.41 |
2025-06-30 | -$0.38 |
